ASLAN Pharmaceuticals

Print Page  |  Close Window

Investor Relations

Investor Home


ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for global markets. The company targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe.

News Releases

03 Jul 2018ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004
17 May 2018ASLAN Pharmaceuticals to Present Two Posters on Varlitinib at ASCO
04 May 2018ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares
Read More

Upcoming Events

There are currently no events scheduled.
Read More

IR Contacts

Investor Relations